Ross Sallade provides value to clients by tackling the complex legal regulatory, operational, reimbursement and enrollment matters that others might be reluctant to handle. Ross does so by drawing upon particular knowledge for each matter which enables him to quickly evaluate urgent issues and provide practical recommendations. He also leverages a unique skill set that enables him to identify and work with the right federal and state regulators to pinpoint the heart of the issue and make recommendations to reach appropriate resolution. His previous experience strengthens his ability to provide counsel rooted in an understanding of not only the law, but also how legal issues or regulatory changes can impact clients’ business goals.

Ross works with clients to help them navigate through the myriad of state and federal health care regulatory challenges facing them. He regularly counsels clients to aid in structuring their business transactions and relationships in compliance with federal and state regulations, including change of ownership requirements, as well as federal anti-kickback statute and federal physician self-referral (or “Stark”) laws.

Ross advises clients regularly on a variety of matters, including:

  • Medicare and Medicaid (and other federal and state payor programs) enrollment 
  • State licensure 
  • Medicare and Medicaid compliance 
  • Provider and supplier reimbursement in both the Medicare and Medicaid programs 
  • Healthcare operational matters 
  • Diligence support in connection with M&A and Finance transactions 
  • Professional service and management service agreements, including “controlled professional corporations” 
  • Fraud and abuse

Ross’s practice focuses on a variety of healthcare provider and supplier types, including, but not limited to:

  • Hospitals, including provider based departments 
  • Hospice and home health agencies 
  • DME suppliers 
  • IDTFs 
  • Imaging providers 
  • Ambulatory surgery centers

Ross Sallade applies his in-depth industry knowledge to highlight potential risk exposure and propose alternative resolutions that address clients’ core concerns, as well as a business-focused approach for each transaction to meet the clients’ expectations.

Education

  • University of Virginia School of Law (J.D., 2000)
    • Virginia Commonwealth University, Medical College of Virginia Campus (Master of Health Administration, 1997)
      • Hampden-Sydney College (B.S., cum laude, 1992)
        • Biology

      Bar Admission

      • North Carolina

      Professional Affiliations

      • American Bar Association
        • Health Law Forum
      • American Health Lawyers Association
      • North Carolina Bar Association
        • Health Law Section
      • North Carolina Society for Healthcare Attorneys
      • Alice Aycock Poe Center for Health Education

      Recognition

      • Selected for inclusion in North Carolina Super Lawyers, 2010-2015
      • Selected for inclusion in Best Lawyers in America® for Health Care Law, 2013-2026
      • Who’s Who in American Law
      • Ranked in Chambers USA: America’s Leading Lawyers for Business, Healthcare, North Carolina, 2022-2025
      Publications
      CMS Announces Temporary Nationwide DMEPOS Medical Supply Company Medicare Enrollment Moratorium
      Key Takeaways On Feb. 27, 2026, the Centers for Medicare & Medicaid Services (CMS) published a notice announcing a six-month nationwide moratorium on the enrollment of certain Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) suppliers in the Medicare program.1   The moratorium was effective on Feb. 27 and applies to all new enrollments and new, separately-enrolled practice locations, including those new enrollments arising from changes in ownership barred by the newly instituted 36-month rule and changes of ownership resulting from asset transfers. The suppliers subject to the moratorium are restricted to medical supply companies and the six related specialty subtypes whose “principle function” is to furnish DMEPOS supplies to beneficiaries and/or medical providers and suppliers. Limitations of the Moratorium Applications received before the effective date
      Read More
      Mandatory Provider-Based Attestations Make a Comeback
      After a nearly 24-year hiatus from the mandatory provider-based attestation requirement, the Consolidated Appropriations Act of 2026 (Act, signed into law on Feb. 3, 2026), mandates (again) that hospitals file attestations of compliance with the provider-based regulations for all off-campus provider-based locations. Attestations must be filed before Jan. 1, 2028, with more specific timing to be further defined by CMS. Failure to do so by that date will result in payment reduction under the Hospital Outpatient Prospective Payment System (OPPS). Key Takeaways Hospitals must file attestations for all off-campus provider-based locations pursuant to either (a) the existing attestation regulations at 42 C.F.R. § 413.65(b)(3) or (b) new regulations that CMS must establish under the Act. All initial attestations must be filed within the
      Read More